ANIKA THERAPEUTICS INC (ANIK)
US0352551081 - Common Stock
Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release
Integrity marks Anika’s entrance into the fast-growing $150 million+2 U.S. rotator cuff augmentation market and expansion of its proprietary hyaluronic...
Anika to Participate in Upcoming Investor Conferences
Anika to Participate in Upcoming Investor Conferences
BEDFORD, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika Therapeutics Non-GAAP EPS of $0.00 beats by $0.35, revenue of $41.5M beats by $3.23M (NASDAQ:ANIK)
Anika Therapeutics beats expectations with Q3 earnings, reporting a non-GAAP EPS of $0.00 and revenue of $41.5M, exceeding estimates by $0.35 and $3.23M...
Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business
Revenue Growth Exceeded Expectations in the Third Quarter and Year-To-Date, with Joint Preservation and Restoration up 14% and 10% and OA Pain Management...
Commit To Buy Anika Therapeutics At $15, Earn 7.1% Annualized Using Options
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
BEDFORD, Mass., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual Meeting
RevoMotion Reverse Shoulder Arthroplasty System significantly expands Anika’s shoulder arthroplasty portfolio and provides a bone conserving and innovative...
Anika Therapeutics is Now Oversold (ANIK)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BEDFORD, Mass., Sept. 15, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
BEDFORD, Mass., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
ABNB and BX will join Sept. 18 as part of a quarterly rebalancing.
3 Sorry Penny Stocks to Sell in August Before It’s Too Late
As interest rates rise and money becomes more expensive, investors may look to get rid of these penny stocks set to fail.
Anika Receives 510(k) Clearance for Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Augmentation of Rotator Cuff Repairs
Complete Integrity Implant System is now fully cleared; targeting launch in Q1-2024 Integrity is highly differentiated by its knitted structure,...
Anika Reports Second Quarter 2023 Financial Results
Double Digit Q2 Revenue Growth Driven by Strong OA Pain Management Growth of 22%; Raising Low-End of Full-Year Guidance Range on Positive Year-to-Date...
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
Anika to Issue Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
BEDFORD, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
Anika Showcases Highly Differentiated Joint Preservation and Restoration Portfolio at the 2023 AOSSM Annual Meeting
Anika’s new X-Twist™ Fixation System, combined with its ACE Award-Winning Tactoset® for hardware augmentation and autologous bone morrow aspirate, provide...
Anika Therapeutics Enters Oversold Territory (ANIK)
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
Hyalofast – a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair – is marketed in over 35 countries outside the U.S....
Oversold Conditions For Anika Therapeutics (ANIK)
Anika Therapeutics GAAP EPS of -$0.71 misses by $0.37, revenue of $37.9M beats by $0.54M (NASDAQ:ANIK)
Anika Therapeutics press release (ANIK): Q1 GAAP EPS of -$0.71 misses by $0.37.Revenue of $37.9M (+3.3% Y/Y) beats by $0.54M.
Anika Reports First Quarter 2023 Financial Results
Positive Start to 2023 Revenue Growth with OA Pain Management Up 8% and Joint Preservation and Restoration Up 11%...
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
Anika to Issue First Quarter 2023 Financial Results on Tuesday, May 9, 2023
BEDFORD, Mass., April 19, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...
Anika Enters Into Cooperation Agreement with Caligan Partners
Anika Enters Into Cooperation Agreement with Caligan Partners
Gary Fischetti Joins Anika Board Announces Share Repurchase Program Forms Capital Allocation Committee BEDFORD, Mass., April 13, 2023 (GLOBE NEWSWIRE)...
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
Anika to Participate in the 22nd Annual Needham Virtual Healthcare Conference
BEDFORD, Mass., April 12, 2023 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention...